Shine - a Midnight Marathon walking for Cancer
In 2011 I did my first Shine walk through a moonlit London. It was very emotional yet exhilerating.
I did this with a fantastic bunch of friends met through Twitter. You can read my story here.
I shall be doing the 2012 London Shine marathon on September 29th, and dedicate it to my Nana. She was the strong woman who nurtured me. Sadly she died of bowel cancer in 1994. Every year I light a candle on her birthday, 30th November. The candle shines for me, as my Nana shone for me. I will now Shine for her and wear her name with pride. The 2012 route is slightly different so I shall be waddling through some of her favourite London Landmarks too.
Bowel cancer is diagnosed in about 38,600 people in the UK every year – that’s more than 100 every day. Thanks to improved treatment and earlier detection, five-year survival rates for bowel cancer have doubled over the last 30 years. But sadly, it is still the second most common cause of cancer death in the UK, claiming around 44 lives each day.
Cancer Research UK is the largest single funder of bowel cancer research in the UK. We fund research into all aspects of the disease.
Our scientists are playing a leading role in identifying the genes that increase therisk of developing bowel cancer, and in testing new treatments for the disease.
Over half of people diagnosed with bowel cancer will now survive beyond five years. Our ambition is to further improve on this by finding new ways to prevent, diagnose and treat the disease.
Our bowel cancer researchProfessor Alan Clarke is Director of the Cancer Research UK Centre in Cardiff and a pioneer in his field. Together with his team of researchers, he is carrying out some of the most advanced genetic science in the world.
To save more lives from bowel cancer, we need a better understanding of the disease. It’s only with this knowledge that more targeted and more effective treatments can be created, transforming the outlook for future bowel cancer patients.
Professor Clarke’s team is aiming to understand the tiny genetic alterations in our cells which set off the catastrophic chain of events that leads to bowel cancer. They have already found two a range of molecules that are involved in bowel cancer growth.
The next step is to develop ways to switch off these molecules, turning the team’s lab discoveries into life-saving treatments for people with bowel cancer.
“If we understand why a cancer grows, then we stand a much better chance of creating targeted treatments that can put a stop to it”
Professor Alan Clarke
I did this with a fantastic bunch of friends met through Twitter. You can read my story here.
I shall be doing the 2012 London Shine marathon on September 29th, and dedicate it to my Nana. She was the strong woman who nurtured me. Sadly she died of bowel cancer in 1994. Every year I light a candle on her birthday, 30th November. The candle shines for me, as my Nana shone for me. I will now Shine for her and wear her name with pride. The 2012 route is slightly different so I shall be waddling through some of her favourite London Landmarks too.
Bowel cancer is diagnosed in about 38,600 people in the UK every year – that’s more than 100 every day. Thanks to improved treatment and earlier detection, five-year survival rates for bowel cancer have doubled over the last 30 years. But sadly, it is still the second most common cause of cancer death in the UK, claiming around 44 lives each day.
Cancer Research UK is the largest single funder of bowel cancer research in the UK. We fund research into all aspects of the disease.
Our scientists are playing a leading role in identifying the genes that increase therisk of developing bowel cancer, and in testing new treatments for the disease.
Over half of people diagnosed with bowel cancer will now survive beyond five years. Our ambition is to further improve on this by finding new ways to prevent, diagnose and treat the disease.
Our bowel cancer researchProfessor Alan Clarke is Director of the Cancer Research UK Centre in Cardiff and a pioneer in his field. Together with his team of researchers, he is carrying out some of the most advanced genetic science in the world.
To save more lives from bowel cancer, we need a better understanding of the disease. It’s only with this knowledge that more targeted and more effective treatments can be created, transforming the outlook for future bowel cancer patients.
Professor Clarke’s team is aiming to understand the tiny genetic alterations in our cells which set off the catastrophic chain of events that leads to bowel cancer. They have already found two a range of molecules that are involved in bowel cancer growth.
The next step is to develop ways to switch off these molecules, turning the team’s lab discoveries into life-saving treatments for people with bowel cancer.
“If we understand why a cancer grows, then we stand a much better chance of creating targeted treatments that can put a stop to it”
Professor Alan Clarke
You can sponsor me by texting 70070 NANA93 £3
Team Shine
